No headlines found.
No press releases found.
No news found.
The ARK DIET Q1 Buffer ETF's ("Fund") investment objective is capital appreciation with a measure of downside protection. The Fund is an actively-managed ETF that, for rolling 12-month periods from January 1 to December 31 seeks to provide investors with a defined risk-return profile, before fees and expenses. Specifically, the Fund is structured to provide, before fees and expenses, 50% downside participation in the share price of the ARK Innovation ETF (the "Underlying ETF"), measured from its value at the beginning of each Outcome Period (the "downside participation offset"). In other words, the strategy reduces downside exposure by half relative to the Underlying ETF. The Fund's investment strategy is designed to deliver targeted outcomes that may only be realized if Fund shares are bought by the first day of the Outcome Period and held until the end of the Outcome Period.
Ark Diet Q1 Buffer ETF trades on the BATS stock market under the symbol ARKD.
As of January 22, 2026, ARKD stock price was flat at $20.51 with 5 million shares trading.
ARKD has a market cap of $1.54 million. This is considered a Sub-Micro Cap stock.
ARKD support price is $20.28 and resistance is $20.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARKD shares will trade within this expected range on the day.
